Eton Pharmaceuticals, Inc. (ETON)
51.19
+1.02
(+2.03%)
USD |
NASDAQ |
Oct 27, 16:00
51.90
+0.71
(+1.39%)
After-Hours: 20:00
Eton Pharmaceuticals Cash from Investing (Quarterly) : 0.005M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.005M |
| March 31, 2026 | -15.08M |
| December 31, 2025 | -0.049M |
| September 30, 2025 | -0.284M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | -38.13M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | -1.882M |
| December 31, 2023 | -0.775M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.012M |
| September 30, 2022 | -2.00M |
| June 30, 2022 | -0.761M |
| March 31, 2022 | -0.015M |
| Date | Value |
|---|---|
| December 31, 2021 | -3.254M |
| September 30, 2021 | -0.002M |
| June 30, 2021 | 0.697M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.044M |
| September 30, 2020 | -0.002M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -0.004M |
| December 31, 2019 | -0.784M |
| September 30, 2019 | -0.032M |
| June 30, 2019 | -0.642M |
| March 31, 2019 | -0.388M |
| December 31, 2018 | -0.054M |
| September 30, 2018 | -0.05M |
| June 30, 2018 | -0.041M |
| March 31, 2018 | -0.091M |
| December 31, 2017 | -0.005M |
| September 30, 2017 | -0.117M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aquestive Therapeutics, Inc. | -0.212M |
| Pfizer Inc. | 2.106B |
| Elite Pharmaceuticals, Inc. | -0.809M |
| Daré Bioscience, Inc. | -0.0806M |
| Liquidia Corp. | -12.24M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.255M |
| Cash from Financing (Quarterly) | -0.076M |
| Free Cash Flow | -0.268M |
| Free Cash Flow Per Share (Quarterly) | 0.2214 |
| Free Cash Flow to Equity (Quarterly) | 9.297M |
| Free Cash Flow to Firm (Quarterly) | 9.593M |
| Free Cash Flow Yield | -0.02% |